Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed: 18,156
Companies: 1,062
Drugs tracked: 3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources

Quick answer

Sinovac Low-dosage PCV24

Sinovac PCV24

Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28

Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28

low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated

pandemic influenza vaccine (H5N1 strain NIBRG-14)

100U inactivated Enterovirus Type 71 Vaccine

Inactivated Enterovirus Type 71 Vaccine

Investigational 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

Low-dose RSV mRNA vaccine

One dose of investigational vaccine

SA55 Injection

SA55 nasal spray

Sinovac PCV24 formulation 1

an inactivated whole virion H5N1 vaccine, adjuvanted

high-dose Group ACYW135X Meningococcal Conjugate Vaccine

pandemic influenza vaccine (H5N1 strain NIBRG-14)

2 doses of HAV

2012-2013 trivalent seasonal influenza vaccine

2wIPV+1sIPV

5000 volunteers (6-35 months)-EV71 vaccine

Adult group in immunogenicity and safety study of combined immunization

COVID-19 Vaccine (Vero cell), Inactivated

Combined vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine

Frequently asked questions